Horizon Therapeutics
Horizon Therapeutics is a biopharmaceutical company that focuses on the research, development, and commercialization of medicines for the treatment of rare, autoimmune, and severe inflammatory diseases. The company was founded in 2008 and is headquartered in Dublin, Ireland, with U.S. operations based in Lake Forest, Illinois.
History[edit | edit source]
Horizon Therapeutics was established in 2008 with the aim of developing innovative medicines for patients suffering from rare and severe diseases. The company has since grown to become a global leader in the biopharmaceutical industry, with a diverse portfolio of products and a robust pipeline of potential new therapies.
Products[edit | edit source]
Horizon Therapeutics' product portfolio includes a range of medicines designed to treat rare, autoimmune, and severe inflammatory diseases. These include Ravicti, Buphenyl, Procysbi, and Actimmune, among others. Each of these products has been developed using the company's proprietary technology and scientific expertise.
Research and Development[edit | edit source]
Research and development (R&D) is a key focus for Horizon Therapeutics. The company invests heavily in R&D, with a particular emphasis on the development of new therapies for rare and severe diseases. This commitment to R&D has resulted in a strong pipeline of potential new products, which are currently in various stages of clinical development.
Financial Performance[edit | edit source]
Horizon Therapeutics has demonstrated strong financial performance since its inception. The company's revenue has grown steadily, driven by strong sales of its key products and successful launches of new therapies. In addition, the company has a solid financial position, with a healthy balance sheet and strong cash flow.
See Also[edit | edit source]
References[edit | edit source]
| <img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Searchtool.svg/40px-Searchtool.svg.png" alt="Stub icon" width="40" height="40" /> | This biopharmaceutical related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
